Development and validation of a screening test for 12 common mutations of the cystic fibrosis CFTR gene

European Respiratory Journal

Volumn 12, Issue 2, 1998, Pages 477-482

  Robertson, N H ^a   Weston, S L ^a   Kelly, S J ^a   Duxbury, N J ^a   Pearce, S R ^a   Elsmore, P ^a   Webb, M B T ^a   Newton, C R ^a   Little, S ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

ARMS CFTR gene; Cystic fibrosis; Genetic screening

Indexed keywords

DNA POLYMERASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CYSTIC FIBROSIS; DNA SEQUENCE; DNA TEMPLATE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGULATOR GENE; SCREENING TEST;

EID: 0031844312     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12020477     Document Type: Article

References (20)

1. Welsh MJ, Tsui L-C, Boat TF, Beadudet AL. In: Scriver CR, Beaudet AL, Sly WL, Valle D, eds. The metabolic and molecular bases of inherited disease. New York, McGraw-Hill, 1990; pp. 3799-3876.
2. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis current survival and population estimates to the year 2000. Thorax 1991; 46: 881-885.
3. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
4. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucl Acids Res 1989; 17: 2503-2516.
5. Newton CR, Schwarz M, Summers C, et al. Detection of delta-F508 deletion by amplification refractory mutation system. Lancet 1990; 335: 1217-1219.
6. Ballabio A, Gibbs RA, Caskey CT. PCR test for cystic fibrosis deletion. Nature 1990; 343: 220.
7. Wagner M, Schloesser M, Reiss J. Direct gene diagnosis of cystic fibrosis by allele-specific polymerase chain reactions. Mol Biol Med 1990; 7: 359-364.
8. Ferrie RM, Schwarz MJ, Robertson NH, et al. Development multiplexing and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet 1992; 51: 251-262.
9. Fortina P, Conant R, Monokian G, et al. Non-radioactive detection of the most common mutations in the cystic fibrosis transmembrane conductance regulator gene by multiplex allele-specific polymerase chain reaction. Hum Genet 1992; 90: 375-378.
10. Kazazian HH. Population variation of common cystic fibrosis mutations. Hum Mutat 1994; 4: 167-177.
11. UK Patent Application No. 9800536.6.
12. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
13. Super M, Schwarz MJ, Malone G, Roberts T, Haworth A, Dermody G. Active cascade testing for carriers of cystic fibrosis gene. BMJ 1994; 308: 1462-1467.
14. Wald NJ. Couple screening for cystic fibrosis. Lancet 1991; 338: 1318-1319.
15. Gilfillan A, Axton R, Brock DJH. Mass screening for cystic fibrosis heterozygotes: two assay systems compared. Clin Chem 1994; 40: 197-199.
16. Livingstone J, Axton RA, Gilfillan A, et al. Antenatal screening for cystic fibrosis: a trial of the couple model. BMJ 1994; 308: 1459-1462.
17. Morris JK, Oppenheimer PM. Cost comparison of different methods of screening for cystic fibrosis. J Med Screen 1995; 2: 22-77.
18. Harris H, Scotcher D, Hartley N, Wallace A, Craufurd D, Harris R. Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice. Br J Gen Pract 1996; 46: 225-227.
19. Findlay I, Cuckle H, Lilford RJ, Rutherford RJ, Quirke P, Lui S. Screening sperm donors for cystic fibrosis. BMJ 1995; 310: 1533.
20. Cuppens H, Cassiman JJ. A quality control study of CFTR mutation screening in 40 different European laboratories: the European concerted action on cystic fibrosis. Eur J Hum Genet 1995; 3: 235-245.